www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 10 May 2026 12:43:35 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netSun, 10 May 2026 06:21:35 +0200https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-abivax-sa-praesentiert-quartalsergebnisse-15673380Abivax SA wird voraussichtlich am 25.05.2026 die Geschäftsergebnisse zum jüngsten Jahresviertel vorstellen.Die Prognosen von 5 Analysten belaufen sich für das jüngste Jahresviertel durchschnittlich auf ein EPS von ...

]]>https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-abivax-sa-praesentiert-quartalsergebnisse-15673380Tue, 05 May 2026 08:00:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares-15658990

EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares 05.05.2026 / 08:00 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares-15658990Wed, 22 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-to-present-data-on-obefazimod-at-digestive-disease-week-15628075 EQS-News: ABIVAX / Key word(s): Conference Abivax to Present Data on Obefazimod at Digestive Disease Week® 22.04.2026 / 22:05 CET/CEST The issuer is solely responsible for ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-to-present-data-on-obefazimod-at-digestive-disease-week-15628075Mon, 20 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents-15621989 EQS-News: ABIVAX / Key word(s): AGM/EGM Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents 20.04.2026 / 22:05 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents-15621989Wed, 01 Apr 2026 22:05:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies-15590201 EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies 01.04.2026 / 22:05 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies-15590201Fri, 27 Mar 2026 10:50:00 +0100https://www.finanzen.net/nachricht/fonds/wochenschwerpunkt-trampolin-boerse-15580608https://www.finanzen.net/nachricht/fonds/wochenschwerpunkt-trampolin-boerse-15580608Thu, 26 Mar 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/abivax-sa-bilanzvorlage-zum-letzten-quartal-15577417Abivax SA hat am 23.03.2026 die Bilanz zum am 31.12.2025 abgelaufenen Quartal präsentiert.Das Ergebnis je Aktie fiel für das Gesamtjahr negativ aus. Der Verlust je Papier wurde auf 4,830 EUR beziffert. Im Vorjahr ... ]]>https://www.finanzen.net/nachricht/aktien/abivax-sa-bilanzvorlage-zum-letzten-quartal-15577417Mon, 23 Mar 2026 21:05:03 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-full-year-2025-financial-results-and-provides-business-updates-15572465 EQS-News: ABIVAX / Key word(s): Annual Results Abivax Announces Full Year 2025 Financial Results and Provides Business Updates 23.03.2026 / 21:05 CET/CEST The issuer is solely ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-announces-full-year-2025-financial-results-and-provides-business-updates-15572465Sat, 21 Feb 2026 12:00:04 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-presents-first-evidence-of-anti-fibrotic-activity-for-obefazimod-alongside-new-clinical-efficacy-and-safety-analyses-in-inflammatory-bowel-disease-at-ecco-2026-15507571 EQS-News: ABIVAX / Key word(s): Study results Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-abivax-presents-first-evidence-of-anti-fibrotic-activity-for-obefazimod-alongside-new-clinical-efficacy-and-safety-analyses-in-inflammatory-bowel-disease-at-ecco-2026-15507571Fri, 20 Feb 2026 09:15:00 +0100https://www.finanzen.net/nachricht/aktien/small-cap-statt-big-tech-mit-nebenwerten-auf-der-ueberholspur-15505342https://www.finanzen.net/nachricht/aktien/small-cap-statt-big-tech-mit-nebenwerten-auf-der-ueberholspur-15505342